157 related articles for article (PubMed ID: 19764350)
1. The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line.
Kuo HS; Hsu FN; Chiang MC; You SC; Chen MC; Lo MJ; Lin H
Chin J Physiol; 2009 Feb; 52(1):23-30. PubMed ID: 19764350
[TBL] [Abstract][Full Text] [Related]
2. Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5.
Goodyear S; Sharma MC
Exp Mol Pathol; 2007 Feb; 82(1):25-32. PubMed ID: 17081516
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-β1 induces cell cycle arrest by activating atypical cyclin-dependent kinase 5 through up-regulation of Smad3-dependent p35 expression in human MCF10A mammary epithelial cells.
Park SJ; Yang SW; Kim BC
Biochem Biophys Res Commun; 2016 Apr; 472(3):502-7. PubMed ID: 26966064
[TBL] [Abstract][Full Text] [Related]
4. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
Lee JH; Kim KT
J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
Eggers JP; Grandgenett PM; Collisson EC; Lewallen ME; Tremayne J; Singh PK; Swanson BJ; Andersen JM; Caffrey TC; High RR; Ouellette M; Hollingsworth MA
Clin Cancer Res; 2011 Oct; 17(19):6140-50. PubMed ID: 21825040
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis.
Lin H; Juang JL; Wang PS
J Biol Chem; 2004 Jul; 279(28):29302-7. PubMed ID: 15123618
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid induces DU145 cell cycle arrest through Cdk5 activation.
Lin E; Chen MC; Huang CY; Hsu SL; Huang WJ; Lin MS; Wu JC; Lin H
Cell Physiol Biochem; 2014; 33(6):1620-30. PubMed ID: 24851929
[TBL] [Abstract][Full Text] [Related]
9. Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia.
Bosutti A; Qi J; Pennucci R; Bolton D; Matou S; Ali K; Tsai LH; Krupinski J; Petcu EB; Montaner J; Al Baradie R; Caccuri F; Caruso A; Alessandri G; Kumar S; Rodriguez C; Martinez-Gonzalez J; Slevin M
PLoS One; 2013; 8(9):e75538. PubMed ID: 24098701
[TBL] [Abstract][Full Text] [Related]
10. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
Zhang Y; Li H; Hao J; Zhou Y; Liu W
Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis.
Zheng YL; Zhang X; Fu HX; Guo M; Shukla V; Amin ND; E J; Bao L; Luo HY; Li B; Lu XH; Gao YC
PLoS One; 2016; 11(8):e0160252. PubMed ID: 27479491
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration.
Lampropoulou E; Logoviti I; Koutsioumpa M; Hatziapostolou M; Polytarchou C; Skandalis SS; Hellman U; Fousteris M; Nikolaropoulos S; Choleva E; Lamprou M; Skoura A; Megalooikonomou V; Papadimitriou E
Sci Rep; 2018 Apr; 8(1):5893. PubMed ID: 29651006
[TBL] [Abstract][Full Text] [Related]
13. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
Schmid G; Strosznajder JB; Wesierska-Gadek J
Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p35 in Min6 pancreatic beta cells induces a stressed neuron-like apoptosis.
Zheng YL; Hu YF; Zhang A; Wang W; Li B; Amin N; Grant P; Pant HC
J Neurol Sci; 2010 Dec; 299(1-2):101-7. PubMed ID: 20926102
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC12 cells.
Chen MC; Lin H; Hsu FN; Huang PH; Lee GS; Wang PS
Am J Physiol Cell Physiol; 2010 Aug; 299(2):C516-27. PubMed ID: 20463173
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-mediated growth inhibition of small cell lung cancer cells is associated with reduced myc and increased p27Kip1 expression.
Weber E; Ravi RK; Knudsen ES; Williams JR; Dillehay LE; Nelkin BD; Kalemkerian GP; Feramisco JR; Mabry M
Int J Cancer; 1999 Mar; 80(6):935-43. PubMed ID: 10074929
[TBL] [Abstract][Full Text] [Related]
17. Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway.
Demelash A; Rudrabhatla P; Pant HC; Wang X; Amin ND; McWhite CD; Naizhen X; Linnoila RI
Mol Biol Cell; 2012 Aug; 23(15):2856-66. PubMed ID: 22696682
[TBL] [Abstract][Full Text] [Related]
18. Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival.
Zheng YL; Li BS; Kanungo J; Kesavapany S; Amin N; Grant P; Pant HC
Mol Biol Cell; 2007 Feb; 18(2):404-13. PubMed ID: 17108320
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells.
Strock CJ; Park JI; Nakakura EK; Bova GS; Isaacs JT; Ball DW; Nelkin BD
Cancer Res; 2006 Aug; 66(15):7509-15. PubMed ID: 16885348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]